NCT00566878

Pompe Lactation Sub-Registry

A Sub-Registry to Determine the Presence of Alglucosidase Alfa in Breast Milk From Women With Pompe Disease Treated With Alglucosidase Alfa.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2 (actual)
• Sponsor: Genzyme, a Sanofi Company · Industry
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

The objective is to determine if alglucosidase alfa is present in breast milk from mothers with Pompe Disease being treated with alglucosidase alfa and to measure breast milk production and composition in women with Pompe Disease who receive alglucosidase alfa.

Conditions

• Glycogen Storage Disease
• Pompe Disease

Interventions

Type	Name	Description
BIOLOGICAL	alglucosidase alfa	At least one infusion of alglucosidase alfa post partum

Timeline

• Start date: 2012-03-31
• Primary completion: 2024-02-09
• Completion: 2024-02-09
• First posted: 2007-12-04
• Last updated: 2024-03-19

Locations

2 sites across 1 country: United States